Tango Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	788	1,010	639	958	245	-
Market Cap Growth	-	57.94%	-33.25%	291.63%	-	-
Enterprise Value	483	711	314	473	62	-34
PE Ratio	-9.92	-9.92	-5.91	-16.45	-4.71	-
PS Ratio	21.42	27.64	25.72	25.86	31.94	-
PB Ratio	3.09	3.99	2.56	2.78	6.34	-
P/FCF Ratio	-8.45	-8.45	-5.47	-15.61	3.55	-
P/OCF Ratio	-8.56	-8.56	-5.86	-16.09	3.49	-
EV/Sales Ratio	13.23	19.46	12.62	12.78	8.11	-1.39
EV/EBITDA Ratio	-7.44	-7.44	-3.01	-8.46	-1.23	2.71
EV/EBIT Ratio	-7.00	-7.00	-2.90	-8.17	-1.20	2.42
EV/FCF Ratio	-5.95	-5.95	-2.69	-7.72	0.90	1.28
Debt / Equity Ratio	0.15	0.15	0.16	0.00	0.20	-0.18
Debt / EBITDA Ratio	-0.41	-0.41	-0.40	-0.03	-0.16	-0.68
Debt / FCF Ratio	-0.33	-0.33	-0.35	-0.02	0.11	-0.32
Quick Ratio	7.35	7.35	6.64	11.99	4.70	1.65
Current Ratio	7.54	7.54	6.76	12.10	4.73	1.61
Asset Turnover	0.09	0.09	0.06	0.10	0.06	-
Return on Equity (ROE)	-42.00%	-42.00%	-37.90%	-47.60%	1130.40%	-
Return on Assets (ROA)	-25.20%	-25.20%	-23.80%	-15.80%	-39.50%	-
Return on Capital (ROIC)	-39.10%	-39.10%	-38.22%	-16.81%	-112.30%	38.62%
Earnings Yield	-13.01%	-10.08%	-16.92%	-6.08%	-21.25%	-
FCF Yield	-15.28%	-11.84%	-18.27%	-6.41%	28.20%	-
Buyback Yield / Dilution	-7.69%	-7.69%	-41.40%	-94.50%	-255.37%	-
Total Shareholder Return	-7.69%	-7.69%	-41.40%	-94.50%	-255.37%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).